Health Genomics

Introduction Lung cancer remains one of the leading causes of cancer-related mortality worldwide. The complexity of this disease lies in its heterogeneity—different genetic and molecular subtypes often demand diverse therapeutic approaches. This is where pharmacogenomics (PGx) comes into play, allowing treatments to be tailored based on an individual’s genetic makeup. Onco PGx, a specialized genetic […]

Advancements in precision medicine are transforming cancer care, with Onco PGx (Oncology Pharmacogenomics) playing a pivotal role in personalizing chemotherapy for breast cancer. Onco PGx integrates genetic insights with pharmacological data to optimize treatment efficacy, minimize adverse effects, and reduce trial-and-error approaches in therapy selection. By analyzing genetic variations that affect drug metabolism and response,

Colorectal cancer (CRC) remains a significant global health challenge, necessitating continuous advancements in treatment strategies. Chemotherapy, a cornerstone of CRC management, often presents a trade-off between efficacy and toxicity. Inter-individual variability in response to chemotherapy agents highlights the need for personalized approaches. Onco PGx addresses this challenge by analyzing genetic variations that influence how patients